These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis. Vilay AM; Grio M; Depestel DD; Sowinski KM; Gao L; Heung M; Salama NN; Mueller BA Crit Care Med; 2011 Jan; 39(1):19-25. PubMed ID: 20890189 [TBL] [Abstract][Full Text] [Related]
23. Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved Gram-positive infections. Abdel-Rahman SM; Chandorkar G; Akins RL; Bradley JS; Jacobs RF; Donovan J; Benziger DP Pediatr Infect Dis J; 2011 Aug; 30(8):712-4. PubMed ID: 21317681 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis. Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis. Tomino Y; Fukui M; Hamada C; Inoue S; Osada S Arzneimittelforschung; 1998 Aug; 48(8):862-7. PubMed ID: 9748717 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Benziger DP; Pertel PE; Donovan J; Yankelev S; Schwab RJ; Swan SK; Cannon C Clin Nephrol; 2011 Jan; 75(1):63-9. PubMed ID: 21176752 [TBL] [Abstract][Full Text] [Related]
27. [Safety of daptomycin in patients with renal impairment]. Azanza JR; Quetglas EG Med Clin (Barc); 2010 Dec; 135 Suppl 3():55-9. PubMed ID: 21477705 [TBL] [Abstract][Full Text] [Related]
28. Antibiotic dosing during sustained low-efficiency dialysis: special considerations in adult critically ill patients. Bogard KN; Peterson NT; Plumb TJ; Erwin MW; Fuller PD; Olsen KM Crit Care Med; 2011 Mar; 39(3):560-70. PubMed ID: 21221000 [TBL] [Abstract][Full Text] [Related]
29. Daptomycin dosing strategies in patients receiving thrice-weekly intermittent hemodialysis. Haselden M; Leach M; Bohm N Ann Pharmacother; 2013 Oct; 47(10):1342-7. PubMed ID: 24259698 [TBL] [Abstract][Full Text] [Related]
30. [Present significance of home hemodialysis]. Ota K Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1653-7. PubMed ID: 8537719 [No Abstract] [Full Text] [Related]
32. [Clinical guideline review: Standards for initiation of chronic dialysis]. Sakaguchi T; Akizawa T Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1561-9. PubMed ID: 12082749 [No Abstract] [Full Text] [Related]
33. Substitutive treatments in end-stage renal disease. Hemodialysis vs. peritoneal dialysis. La Greca G; Chiaramonte S; Feriani M; Milan M Contrib Nephrol; 1994; 109():45-52. PubMed ID: 7956228 [No Abstract] [Full Text] [Related]
34. Daptomycin-induced acute eosinophilic pneumonia: analysis of the current data and illustrative case reports. Phillips J; Cardile AP; Patterson TF; Lewis JS Scand J Infect Dis; 2013 Oct; 45(10):804-8. PubMed ID: 23826793 [TBL] [Abstract][Full Text] [Related]
35. [Antibiotic therapy for patients with kidney failure and on hemodialysis]. Yoshida A; Kimura G Nihon Naika Gakkai Zasshi; 2006 Nov; 95(11):2197-201. PubMed ID: 17168392 [No Abstract] [Full Text] [Related]
36. Clinical pharmacokinetics during continuous ambulatory peritoneal dialysis. Taylor CA; Abdel-Rahman E; Zimmerman SW; Johnson CA Clin Pharmacokinet; 1996 Oct; 31(4):293-308. PubMed ID: 8896945 [TBL] [Abstract][Full Text] [Related]
37. Possible Hepatotoxicity Associated With Daptomycin: A Case Report and Literature Review. Mo Y; Nehring F; Jung AH; Housman ST J Pharm Pract; 2016 Jun; 29(3):253-6. PubMed ID: 26763341 [TBL] [Abstract][Full Text] [Related]
38. Pharmacotherapeutic consequences of recent advances in hemodialysis therapy. Matzke GR Ann Pharmacother; 1994 Apr; 28(4):512-4. PubMed ID: 8038477 [No Abstract] [Full Text] [Related]